Virco Lab to Market SmartGene's HIV Platform | GenomeWeb

NEW YORK (GenomeWeb News) – HIV resistance testing company Virco Lab will market SmartGene's web-based data management module to HIV researchers.

The SmartGene HIV platform will enable researchers to use both the SmartGene and Virco services to send an order for sequence data interpretation, and then to store the HIV-1resistance reports within their SmartGene database.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.